The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey
Supporting Files
-
-
-
-
Available in CDC Stacks on
File Language:
English
Details
-
Journal Article:Public Health
-
Description:Objectives
The burden of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections is unknown in Georgia. This analysis describes the prevalence of hepatitis B and coinfection with HDV and the demographic characteristics and risk factors for persons with HBV infection in Georgia.
Study Design
A cross-sectional seroprevalence study.
Methods
A cross-sectional, nationwide survey to assess hepatitis B prevalence among the general adult Georgian population (age ≥18 years) was conducted in 2015. Demographic and risk behavior data were collected. Blood specimens were screened for antiehepatitis B core total antibody (anti-HBc). Anti-HBc-positive specimens were tested for hepatitis B surface antigen (HBsAg). HBsAg-positive specimens were tested for HBV and HDV nucleic acid. Nationally weighted prevalence estimates and adjusted odds ratios (aORs) for potential risk factors were determined for anti-HBc and HBsAg positivity.
Results
The national prevalence of anti-HBc and HBsAg positivity among adults were 25.9% and 2.9%, respectively. Persons aged ≥70 years had the highest anti-HBc positivity (32.7%), but the lowest HBsAg positivity prevalence (1.3%). Anti-HBc positivity was associated with injection drug use (aOR = 2.34; 95% confidence interval [CI] = 1.46–3.74), receipt of a blood transfusion (aOR = 1.68; 95% CI = 1.32–2.15), and sex with a commercial sex worker (aOR = 1.46; 95% CI = 1.06–2.01). HBsAg positivity was associated with receipt of a blood transfusion (aOR = 2.72; 95% CI = 1.54–4.80) and past incarceration (aOR = 2.72; 95% CI = 1.25–5.93). Among HBsAg-positive persons, 0.9% (95% CI = 0.0–2.0) were HDV coinfected.
Conclusions
Georgia has an intermediate to high burden of hepatitis B, and the prevalence of HDV coinfection among HBV-infected persons is low. Existing infrastructure for hepatitis C elimination could be leveraged to promote hepatitis B elimination. -
Subjects:
- Article
- Georgia
- Hepatitis B
- Hepatitis D
- Prevalence
- Risk Factors
- Adolescent
- Adult
- Aged
- Coinfection
- Cross-Sectional Studies
- Female
- Hepatitis B Antibodies
- Hepatitis B Surface Antigens
- Hepatitis B virus
- Hepatitis Delta Virus
- Humans
- Male
- Middle Aged
- Seroepidemiologic Studies
- Sex Workers
- Surveys and Questionnaires
- Young Adult
-
DOI:
-
Pubmed ID:32738575
-
Pubmed Central ID:PMC7467099
-
Document Type:
-
Funding:
-
Genre:
-
Volume:185
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:c9f6322ca46ef95eaa42cd9c30216562e7c8cb1e4fe95a2ec8158cfc378e66fd019245597bfc3c17d4b9a7711f008aaf1ecf0d6e46e864bccdfc4773929bea27
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access